The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study

K D Bardhan, A Forbes, C L Marsden, T Mason, G Short

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)


The post-withdrawal characteristics of tegaserod treatment in patients with irritable bowel syndrome with constipation remain undefined.
Original languageEnglish
Pages (from-to)213-222
Number of pages10
JournalAlimentary Pharmacology and Therapeutics
Issue number2
Publication statusPublished - 15 Jul 2004


  • Abdominal Pain
  • Adolescent
  • Adult
  • Aged
  • Constipation
  • Female
  • Flatulence
  • Gastrointestinal Agents
  • Humans
  • Indoles
  • Irritable Bowel Syndrome
  • Male
  • Middle Aged
  • Recurrence
  • Treatment Outcome
  • Withholding Treatment

Cite this